Archive for October, 2011

Journal of Commercial Biotechnology — November 2011 issue now available

The November 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Journal of Commercial Biotechnology Vol 17, Issue 4 (2011) Exciting changes Yali Friedman Full details at the Journal of Commercial Biotechnology New technologies for neglected diseases: Can tax credits help […]


New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?

Biotechnology companies can play an important role in advancing technologies for global health. Initiatives such as Genzyme’s Humanitarian Assistance for Neglected Diseases and Alnylam’s Intellectual Property (IP) contributions to the Pool for Open Inn…


Where in the United States are drugs invented?

Following on the heels of my post on Globalization in the Pharmaceutical Industry, it is also useful to examine the distribution of inventorship across the United States. The stakes aren’t quite as high here — public health and national security don’t come in to play — but there still are important implications for economic development. […]


Pocket Biotechnology Industry Primer and Glossary

I’ve just published the Pocket Biotechnology Industry Primer and Glossary as an ebook. This book, which was previously only available as a printed book, is now available in digital format, which means greater convenience and a significant price reduction. This primer and glossary presents a broad, accessible, and comprehensive overview of the biotechnology industry and […]


Where in the world are drugs invented? Measuring pharmaceutical globalization.

The global locations of drug invention are important for public health, economic development, and national security reasons. Inventors tend to focus on diseases endemic to where they live. This is one of the problems of neglected diseases — there are few/no researchers working on certain diseases, which can lead to significant public health problems. Drugs […]


Moving a foreign biotechnology company to the United States is easy as stealing in church

“What is the biggest challenge in moving a foreign biotechnology company to the United States?” I asked this question at the Delaware-New Jersey-Pennsylvania annual biotechnology conference and received a surprising response. The consensus was neatly stated by one of the panelists: “Moving to the US is like stealing in church.” For all the problems one […]


Now free: Conference on Breathing Additional Life into the Life Sciences

Thanks to a new sponsor, Breathing Additional Life into the Life Sciences is now free. The Journal of Commercial Biotechnology, published by thinkBiotech along with BiotechBlog, is proud to serve as a media sponsor for this upcoming conference on biotechnology development. Reaching the Next Milestone Conference on Breathing Additional Life into the Life Sciences Date: […]


Book Review: From Idea to Web Start-up in 21 Days: Creating bacn.com

What does selling bacon on the Internet have to do with biotechnology business development? Almost nothing! But, that is what makes this book so valuable. From Idea to Web Start-up in 21 Days: Creating bacn.com describes a shoestring venture to develop a simple web store. The founders decided to sell bacon due to the strong market […]


Pharmaceutical globalization: Where are drugs invented?

I’m back from the Filling the Pipeline conference in Boston, where I presented a talk on pharmaceutical globalization. Maintaining control of pharmaceutical drug innovation is key for national security, public health, and economic development. We know that much of late-stage development has gone overseas, but the question remains: Where are drugs invented? Using the DrugPatentWatch […]